We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

9 hedge funds and large institutions have $38.8K invested in Eagle Pharmaceuticals, Inc. in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

86% less funds holding

Funds holding: 65 → 9 (-56)

100% less capital invested

Capital invested by funds: $31.9M → $38.8K (-$31.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 55

Holders
9
Holders Change
-56
Holders Change %
-86.15%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
55
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
+$27.9K
2
XT
XTX Topco
Cayman Islands
+$3.3K

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$8.79M
2
ACM
AIGH Capital Management
Maryland
-$4.52M
3
Citigroup
Citigroup
New York
-$3.73M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.16M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
JF
51
Jump Financial
Illinois
– -$40K -10,734 Closed
PAS
52
Point72 Asia (Singapore)
Singapore
– -$29K -7,773 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
– -$22.9K -6,152 Closed
W
54
WealthCollab
Washington
– -$21K -5,617 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$10.1K -2,702 Closed
HWM
56
HighMark Wealth Management
Minnesota
– -$8.21K -2,200 Closed
HT
57
Headlands Technologies
Illinois
– -$6.24K -1,674 Closed
Group One Trading
58
Group One Trading
Illinois
– -$2.93K -785 Closed
UBS Group
59
UBS Group
Switzerland
– -$1.79K -480 Closed
CAL
60
Capital Advisors Ltd
Ohio
– -$1K -149 Closed
Osaic Holdings
61
Osaic Holdings
Arizona
– -$391 -105 Closed
GRP
62
Global Retirement Partners
California
– -$183 -49 Closed
FRA
63
Front Row Advisors
California
– -$149 -40 Closed
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
– -$104 -28 Closed
1 2
3

EGRX Hedge Fund Activity: Q4 2024 in Review

9 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q4 2024, worth a combined $38.8K — down 100% from $31.9M a quarter earlier.

Sellers outnumbered buyers: 55 funds closed out of EGRX and 0 opened new positions — a net loss of 55 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Simplex Trading, adding an estimated $27.9K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $8.79M sold.

  • 9 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q4 2024, down from 65 in Q3 2024.
  • Funds reported $38.8K of Eagle Pharmaceuticals, Inc. stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Eagle Pharmaceuticals, Inc. positions in Q4 2024 and 55 closed out, a net change of -55 holders.
  • The largest Eagle Pharmaceuticals, Inc. buyer in Q4 2024 was Simplex Trading, an estimated $27.9K added.
  • The largest Eagle Pharmaceuticals, Inc. seller in Q4 2024 was Nantahala Capital Management, an estimated $8.79M sold.

Based on aggregated 13F filings for Q4 2024.